Abstract
The pharmacokinetics of hydrocortisone were examined following single intravenous doses of 5, 10, 20, and 40 mg hydrocortisone, as the sodium succinate salt, to healthy male volunteers. Endogenous hydrocortisone was suppressed by administration of 2 mg dexamethasone the night before hydrocortisone injection. Plasma samples obtained serially during 8 h after hydrocortisone injection were assayed by reversephase HPLC using a fixed wavelength (254 nm) ultraviolet detector. Initial concentrations of hydrocortisone in plasma were proportional to dose size. The subsequent decline in hydrocortisone concentrations was biphasic, and individual data sets were adequately described in terms of the pharmacokinetic two-compartment open model. Values of pharmacokinetic parameters were similar from the 5, 10, and 20 mg doses. Following the 40 mg dose, the overall elimination rate constant decreased, while the distribution volume, Vdss,and plasma clearance increased, in comparison with the values obtained from lower doses. Changes in the pharmacokinetics of hydrocortisone at high doses may be related to drug concentrationdependent changes in the binding of hydrocortisone to plasma proteins. Previously reported dosedependent changes in some pharmacokinetic parameters following oral hydrocortisone are attributed to absorption rather than distribution or elimination effects.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
A. O. Osol and J. E. Hoover.Remington's Pharmaceutical Sciences, 15th ed., Mack Printing Co., Easton, Pa., 1975.
N. R. Scott and P. F. Dixon. Determination of cortisol in human plasma by reversed-phase high-performance liquid chromatography.J. Chromatogr. 164:29–34 (1979).
J. Q. Rose and W. J. Jusko. Corticosteroid analysis in biological fluids by high-performance liquid chromatography.J. Chromatogr. 162:273–280 (1979).
F. J. Frey, B. M. Frey, and L. Z. Benet. Liquid-chromatographic measurement of endogenous and exogenous glucocorticoids in plasma.Clin. Chem. 25:1944–1947 (1979).
T. J. Goehl, G. M. Sundaresan, and V. K. Prasad. HPLC determination of hydrocortisone in human plasma using a fluorometric detector.J. Pharm. Sci. 68:1374–1376 (1979).
T. Kawasaki, M. Maeda, and A. Tsuiji. Determination of plasma and urinary cortisol by high-performance liquid chromatography using fluorescence derivatization with dansylhydrazine.J. Chromatogr. 163:143–150 (1979).
R. D. Toothaker, G. M. Sundaresan, J. P. Hunt, T. J. Goehl, K. A. Rotenberg, V. K. Prasad, W. A. Craig, and P. G. Welling. Oral hydrocortisone pharmacokinetics: a comparison of fluorescence and ultraviolet HPLC assays for hydrocortisone in plasma.J. Pharm. Sci., in press.
T. J. Goehl, G. M. Sundaresan, J. P. Hunt, V. K. Prasad, R. D. Toothaker, and P. G. Welling. Suppression of endogenous hydrocortisone with dexamethasone.J. Pharm. Sci. 69:1409–1410 (1980).
W. A. Colburn, A. R. DiSanto, S. S. Stubbs, R. E. Monovich, and K. A. DeSante. Pharmacokinetic interpretation of plasma cortisol and cortisone concentrations following a single oral administration of cortisone acetate to human subjects.J. Clin. Pharmacol. 20:428–436 (1980).
MACC Nonlinear Regression Routines. Academic Computer Center, University of Wisconsin-Madison, Madison, Wisc., 1972.
M. Gibaldi and D. Perrier. Trapezoidal rule. In J. Swarbrick (Ed.),Pharmacokinetics. Marcel Dekker, New York, 1975, Appendix 4, pp. 293–296.
J. Neter and W. Wasseman.Applied Linear Statistical Models. Richard D. Irwin, Homewood, Ill., 1974, pp. 474–477, 740–743.
J. G. Wagner.Fundamentals of Clinical Pharmacokinetics. Drug Intelligence Publications, Hamilton, Ill., 1975, pp. 82–90.
P. L. Morselli, V. Marc, S. Garattini, and M. Zaccala. Metabolism of exogenous cortisol in humans.J. Biochem. Pharmacol. 19:1643–1647 (1970).
R. E. Peterson, J. B. Wyngaarden, S. L. Guerra, B. B. Brodie, and J. J. Bunim. The physiological disposition and metabolic fate of hydrocortisone in man.J. Clin. Invest. 34:1779–1794 (1955).
W. R. Beisel, V. C. Diraimondo, P. Y. Chao, J. M. Rosner, and P. H. Forsham. The influence of plasma protein binding on the extra-adrenal metabolism of cortisol in normal hyperthyroid, and hypothyroid subjects.Metabolism 13:942–950 (1964).
P. J. Fell. Kinetic studies or cortisol and synthetic corticosteroids in man.Clin. Endocrinol. 1:65–72 (1972).
J. Kolanowski, M. A. Pizarro, and J. Crabbe. Potentiation of adrenocortical response upon intermittent stimulation with corticotropin in normal subjects.J. Clin. Endocrinol. Metabol. 14:453–465 (1975).
Y. Araki, O. Yokota, T. Kato, M. Kashima, and T. Miyazaki. Dynamics of synthetic corticosteroids in man. In G. Pincus, T. Nakao, and J. F. Tait (Eds.),Steroid Dynamics, Academic Press, New York, 1966, p. 463.
S. E. Tsuei, J. J. Ashley, R. G. Moore, and W. G. McBride. Quantitation of dexamethasone in biological fluids using high-performance liquid chromatography.J. Chromatogr. 145:213–220 (1978).
C. L. Cope. Protein binding of adrenocortical steroids. InAdrenal Steroids and Disease, 2nd ed., J. B. Lippincott, Philadelphia, 1972, Chap. 4, pp. 59–61.
A. A. Sandberg and W. R. Slaunwhite, Jr. Transcortin: a corticosteroid-binding protein of plasma.J. Clin. Invest. 42:51–54 (1963).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Toothaker, R.D., Welling, P.G. Effect of dose size on the pharmacokinetics of intravenous hydrocortisone during endogenous hydrocortisone suppression. Journal of Pharmacokinetics and Biopharmaceutics 10, 147–156 (1982). https://doi.org/10.1007/BF01062332
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01062332